期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Genetically-engineered mouse models for pancreatic cancer:Advances and current limitations 被引量:1
1
作者 Hideaki Ijichi 《World Journal of Clinical Oncology》 CAS 2011年第5期195-202,共8页
Recently,there has been significant progress in the development of genetically-engineered mouse(GEM)models.By introducing genetic alterations and/or signaling alterations of human pancreatic cancer into the mouse panc... Recently,there has been significant progress in the development of genetically-engineered mouse(GEM)models.By introducing genetic alterations and/or signaling alterations of human pancreatic cancer into the mouse pancreas,animal models can recapitulate human disease.Pancreas epithelium-specific endogenous Kras activation develops murine pancreatic intraepithelial neoplasia(mPanIN).Additional inactivation of p16,p53,or transforming growth factor-βsignaling,in the context of Kras activation,dramatically accelerates mPanIN progression to invasive pancreatic ductal adenocarcinoma(PDAC)with abundant stromal expansion and marked fibrosis(desmoplasia).The autochthonous cancer models retain tumor progression processes from pre-cancer to cancer as well as the intact tumor microenvironment,which is superior to xenograft models,although there are some limitations and differences from human PDAC.By fully studying GEM models,we can understand the mechanisms of PDAC formation and progression more precisely,which will lead us to a breakthrough in novel diagnostic and therapeutic methods as well as identification of the origin of PDAC. 展开更多
关键词 PANCREATIC DUCTAL ADENOCARCINOMA Genetically-engineered MOUSE Pancreas epithelium-specific Kras Tumor-stromal interaction TUMOR microenvironment Origin of PANCREATIC DUCTAL ADENOCARCINOMA Murine PANCREATIC intraepithelial neoplasia Acinar-ductal METAPLASIA Inducible genetically-engineered MOUSE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部